Development of a validation instrument in myocardial perfusion imaging: Results of first flow experiments

Research output: Contribution to journalConference articleAcademicpeer-review

31 Downloads (Pure)

Abstract

Institutional diagnostic workflows regarding coronary artery disease (CAD) may differ greatly. Myocardial perfusion imaging (MPI) is a commonly used diagnostic method in CAD, whereby multiple modalities are deployed to assess relative or absolute myocardial blood flow (MBF) (e.g. with SPECT, PET, MR, CT, or combinations). In line with proper clinical decision-making, it is essential to assess institutional MPI test validity by confronting MBF assessment to a ground truth. Our research focuses on developing such validation instrument/method for MPI by means of simulating controlled myocardial perfusion in a phantom flow setup. A first step was made in the process of method development and validation by specifying basic requirements for the phantom flow setup. First tests in CT-MPI were aimed to gain experience in clinical testing, to verify to which extent the set requirements are met, and to evaluate the steps needed to further improve accuracy and reproducibility of measurements. The myocardium was simulated as a static cylinder and placed in a controllable pulsatile flow circuit whereby using flow sensors as reference. First flow experiments were performed for different stroke volumes (20-35 mL/stroke). After contrast injection, dynamic MPI-CT scans (SOMATOM Force, Siemens) were obtained to investigate the relation between first-pass measured and computed flow. We observed a moderate correlation; hence, the required accuracy and reproducibility levels were not met. However, we have gained new insights in factors regarding the measurement setup and MBF computation process that might affect instrument validation, which we will incorporate in future flow setup design and testing.

Original languageEnglish
Article number1057714
JournalSPIE Conference Proceedings
Volume10577
DOIs
Publication statusPublished - 1 Jan 2018
EventSPIE Medical Imaging 2018: Ultrasonic Imaging and Tomography - Marriott Marquis Houston, Houston, United States
Duration: 13 Feb 201815 Feb 2018

Fingerprint

Myocardial Perfusion Imaging
Imaging
Imaging techniques
Blood Flow
Blood
blood flow
Experiment
Coronary Artery Disease
coronary artery disease
Experiments
Reproducibility
Phantom
Stroke
Diagnostics
Pulsatile Flow
Pulsatile flow
Computerized tomography
Workflow
SPECT
stroke volume

Keywords

  • CT
  • flow experiment
  • myocardial perfusion imaging
  • phantom
  • validation

Cite this

@article{15bff704aa0f4b95b4156ac0154a13b0,
title = "Development of a validation instrument in myocardial perfusion imaging: Results of first flow experiments",
abstract = "Institutional diagnostic workflows regarding coronary artery disease (CAD) may differ greatly. Myocardial perfusion imaging (MPI) is a commonly used diagnostic method in CAD, whereby multiple modalities are deployed to assess relative or absolute myocardial blood flow (MBF) (e.g. with SPECT, PET, MR, CT, or combinations). In line with proper clinical decision-making, it is essential to assess institutional MPI test validity by confronting MBF assessment to a ground truth. Our research focuses on developing such validation instrument/method for MPI by means of simulating controlled myocardial perfusion in a phantom flow setup. A first step was made in the process of method development and validation by specifying basic requirements for the phantom flow setup. First tests in CT-MPI were aimed to gain experience in clinical testing, to verify to which extent the set requirements are met, and to evaluate the steps needed to further improve accuracy and reproducibility of measurements. The myocardium was simulated as a static cylinder and placed in a controllable pulsatile flow circuit whereby using flow sensors as reference. First flow experiments were performed for different stroke volumes (20-35 mL/stroke). After contrast injection, dynamic MPI-CT scans (SOMATOM Force, Siemens) were obtained to investigate the relation between first-pass measured and computed flow. We observed a moderate correlation; hence, the required accuracy and reproducibility levels were not met. However, we have gained new insights in factors regarding the measurement setup and MBF computation process that might affect instrument validation, which we will incorporate in future flow setup design and testing.",
keywords = "CT, flow experiment, myocardial perfusion imaging, phantom, validation",
author = "Kamphuis, {Marije E.} and Pelgrim, {Gert Jan} and Greuter, {Marcel J.W.} and Slart, {Riemer H.J.A.} and Slump, {Cornelis H.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1117/12.2286337",
language = "English",
volume = "10577",
journal = "Proceedings of SPIE - the international society for optical engineering",
issn = "0277-786X",
publisher = "SPIE",

}

Development of a validation instrument in myocardial perfusion imaging : Results of first flow experiments. / Kamphuis, Marije E.; Pelgrim, Gert Jan; Greuter, Marcel J.W.; Slart, Riemer H.J.A.; Slump, Cornelis H.

In: SPIE Conference Proceedings, Vol. 10577, 1057714, 01.01.2018.

Research output: Contribution to journalConference articleAcademicpeer-review

TY - JOUR

T1 - Development of a validation instrument in myocardial perfusion imaging

T2 - Results of first flow experiments

AU - Kamphuis, Marije E.

AU - Pelgrim, Gert Jan

AU - Greuter, Marcel J.W.

AU - Slart, Riemer H.J.A.

AU - Slump, Cornelis H.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Institutional diagnostic workflows regarding coronary artery disease (CAD) may differ greatly. Myocardial perfusion imaging (MPI) is a commonly used diagnostic method in CAD, whereby multiple modalities are deployed to assess relative or absolute myocardial blood flow (MBF) (e.g. with SPECT, PET, MR, CT, or combinations). In line with proper clinical decision-making, it is essential to assess institutional MPI test validity by confronting MBF assessment to a ground truth. Our research focuses on developing such validation instrument/method for MPI by means of simulating controlled myocardial perfusion in a phantom flow setup. A first step was made in the process of method development and validation by specifying basic requirements for the phantom flow setup. First tests in CT-MPI were aimed to gain experience in clinical testing, to verify to which extent the set requirements are met, and to evaluate the steps needed to further improve accuracy and reproducibility of measurements. The myocardium was simulated as a static cylinder and placed in a controllable pulsatile flow circuit whereby using flow sensors as reference. First flow experiments were performed for different stroke volumes (20-35 mL/stroke). After contrast injection, dynamic MPI-CT scans (SOMATOM Force, Siemens) were obtained to investigate the relation between first-pass measured and computed flow. We observed a moderate correlation; hence, the required accuracy and reproducibility levels were not met. However, we have gained new insights in factors regarding the measurement setup and MBF computation process that might affect instrument validation, which we will incorporate in future flow setup design and testing.

AB - Institutional diagnostic workflows regarding coronary artery disease (CAD) may differ greatly. Myocardial perfusion imaging (MPI) is a commonly used diagnostic method in CAD, whereby multiple modalities are deployed to assess relative or absolute myocardial blood flow (MBF) (e.g. with SPECT, PET, MR, CT, or combinations). In line with proper clinical decision-making, it is essential to assess institutional MPI test validity by confronting MBF assessment to a ground truth. Our research focuses on developing such validation instrument/method for MPI by means of simulating controlled myocardial perfusion in a phantom flow setup. A first step was made in the process of method development and validation by specifying basic requirements for the phantom flow setup. First tests in CT-MPI were aimed to gain experience in clinical testing, to verify to which extent the set requirements are met, and to evaluate the steps needed to further improve accuracy and reproducibility of measurements. The myocardium was simulated as a static cylinder and placed in a controllable pulsatile flow circuit whereby using flow sensors as reference. First flow experiments were performed for different stroke volumes (20-35 mL/stroke). After contrast injection, dynamic MPI-CT scans (SOMATOM Force, Siemens) were obtained to investigate the relation between first-pass measured and computed flow. We observed a moderate correlation; hence, the required accuracy and reproducibility levels were not met. However, we have gained new insights in factors regarding the measurement setup and MBF computation process that might affect instrument validation, which we will incorporate in future flow setup design and testing.

KW - CT

KW - flow experiment

KW - myocardial perfusion imaging

KW - phantom

KW - validation

UR - http://www.scopus.com/inward/record.url?scp=85047884932&partnerID=8YFLogxK

U2 - 10.1117/12.2286337

DO - 10.1117/12.2286337

M3 - Conference article

VL - 10577

JO - Proceedings of SPIE - the international society for optical engineering

JF - Proceedings of SPIE - the international society for optical engineering

SN - 0277-786X

M1 - 1057714

ER -